Institutional investors control 15.10% of the outstanding shares in AZN. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Major industry. Additionally, during the quarter ended September 2017, these large investors purchased a net $15.0 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PRIMECAP MANAGEMENT CO. Bought 5.5 Million shares of AstraZeneca
FIDELITY MANAGEMENT & RESEARCH C... Bought 4.2 Million shares of AstraZeneca
CAPITAL RESEARCH & MANAGEMENT CO... Bought 4.0 Million shares of AstraZeneca